Healthcare Technology Commercialization

Who This Is For

Three versions of the same problem

If one of these sounds like where you are right now, this is built for you.

Founder / CEO

“We have pilots, customer interest, and technical complexity, but no repeatable path to revenue.”

PE Operating Partner

“The portfolio company has a credible product but needs product-market focus, commercial discipline, and a credible operator to accelerate value creation.”

Solution Provider Executive

“We are winning hospital accounts but accumulating bespoke integrations, security obligations, and roadmap debt faster than scalable revenue.”

What’s At Stake

A strong product is not the same thing as a scalable business

The gap between a working pilot and a repeatable revenue line is where healthcare technology companies actually lose value. This is what closing that gap requires.

Convert pilots into purchase orders

Name the budget owner and the threshold before the pilot starts, not after it ends.

Protect the roadmap

Say no to unfunded, department-specific requests before they become permanent technical debt.

Improve deployment repeatability

Build one hardened core with configuration at the edges, not a bespoke fork per hospital account.

Build credible expansion economics

Model the real twelve to eighteen month sales cycle and the compliance treadmill, not a generic B2B curve.

Why JHG

Operator experience, not generic consulting

This comes from having done it, not from having studied it.

Co-founded Bluvision, a BLE/RTLS platform that became a real supplier inside Mayo Clinic, and led it through acquisition by HID Global in 2016.

Served as VP of Product, IoT at HID Global from 2019 to 2023, running a large, revenue-significant global portfolio and leading the M&A strategy behind HID’s acquisition of GuardRFID.

Holds issued patents in BLE-based location determination and thermal-imaging room-level RTLS.

Has personally navigated hospital credentialing, IT security review, and EHR integration cycles at Mayo Clinic and other flagship health systems, not just advised on them from the outside.

Brings a firsthand diagnosis of why strong products stall inside larger organizations, the exact lens PE operating partners need for portfolio commercialization work.

Engagement Models

Ways to work together

Every engagement starts with a scoped diagnostic, not an open-ended retainer.

Pilot-to-Product Assessment

A structured review of your active pilots against budget ownership, conversion metrics, and scope boundaries.

Product & Platform Strategy

Fractional CPO leadership to design a module-by-module roadmap mapped to real department buyers.

Fractional CTO Leadership

A hardened technical core with configuration at the edges, built to scale across accounts without a rebuild.

Technology Diligence

For PE firms evaluating a healthcare technology asset, an operator-level read on product debt and expansion risk.

Post-Acquisition Acceleration

Product-line leadership for a stranded or underleveraged asset inside a larger organization.

Free Resource

The Healthcare Pilot Conversion Scorecard

A short checklist to score whether an active hospital pilot is actually a commercial opportunity, or free R&D for an innovation office.

Request the Scorecard

Named purchase-order owner
Budget source: capital, operating, departmental, innovation, or grant
Predefined success metric and threshold
Required cybersecurity, integration, and credentialing gates
Commercial conversion date and procurement path
Scope boundaries and separately priced expansion conditions
Champion authority and executive sponsorship
Replicability across the next ten accounts

Start Here

Request a Confidential Commercialization Diagnostic

A focused conversation on where your pilots actually stand, what is protecting your roadmap, and what is quietly putting it at risk.

Request the Diagnostic